Related Experiment Video

Updated: Jun 2, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

[Role of statins in patients with acute coronary syndromes]

Stefano Urbinati1, Graziana Labanti, Simona Gambetti

  • 1U.O.C. di Cardiologia, Ospedale Bellaria, Bologna. stefano.urbinati@ausl.bo.it

Giornale Italiano Di Cardiologia (2006)
|April 16, 2011
PubMed

Insights

Ten years of statin research in acute coronary syndromes shows reduced events. An intensive statin strategy improves short-term prognosis but has frequent side effects, necessitating a shift towards long-term sustainable approaches.

Area of Science:

  • Cardiology
  • Pharmacology

Context:

  • Statins are widely used for acute coronary syndromes (ACS).
  • A decade of research has provided insights into their efficacy and limitations.

Purpose:

  • To review the lessons learned from 10 years of statin studies in ACS.
  • To evaluate the effectiveness and challenges of intensive statin therapy.
  • To propose future research directions for optimizing statin use in ACS.

Summary:

  • Statin therapy in ACS demonstrably reduces subsequent coronary events.
  • Intensive high-dose statin regimens improve prognosis within 4-6 months but are associated with frequent side effects and treatment discontinuation.
  • The current "lower the better" paradigm may need to evolve towards "long-term sustainability" with tailored strategies.

Impact:

  • Highlights the need for a balanced approach to statin therapy in ACS, considering both efficacy and tolerability.
  • Suggests the development of new strategies for long-term statin use in ACS patients.
  • Underscores the importance of target-oriented studies to determine optimal LDL cholesterol levels for sustained prognostic benefit.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...